Hacker News new | ask | show | jobs
by lxm 1116 days ago
In theory then a bunch of pharma startups that have nailed their marketing costs should then flood the market with cheap new stuff. Why haven't they?
1 comments

What incentive is there to do that? Is there anything preventing them from being gobbled up by current giants?
Being gobbled up at a premium is a reasonable exit strategy.
Well yea, but OP wondered where are these cheap drugs.